Forward Price-to-Revenue Multiple: Maximus Corp (MMS)

Corporate emblem and logo of Maximus, Inc. (MMS)

Cloud-based digitalization of document workflows minimizes data management costs for Maximus, Inc. (MMS). The forward P/S multiple, with GURU.Markets data illustrated on this chart, shows that the latest reading is 0.50. The implementation of RPA automation within Medicaid enhances profitability, while an exceptional level of trust from US authorities guarantees the fundamental stability of the business.

MMS Maximus Inc: Market Cap to Expected Sales Ratio in the range 07/04/2022 - 11/13/2026

Analytical breakdowns for Maximus, Inc.

- market price and analyst price targets:
Price Chart Maximus|MMS - Consensus Target
- company stock exchange capitalization indicators:
Market Valuation Maximus Health|MMS - Enterprise Value
- business book valuation details:
Net Assets per Single Share Maximus|MMS - Book Valuation of Business|Market Cap to Net Assets Ratio maximus.com|MMS - Aggregate Asset Value
- issuer credit burden and liquidity indicators:
Total Debt to Capital Maximus, Inc.|MMS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Maximus, Inc.|MMS - Company Aggregate Debt|Debts to Book Capitalization Maximus Health|MMS - Company Long-Term Liabilities|Company Current Liabilities Maximus|Quick Liquidity maximus.com
- business earnings and investment ratios data:
MMS - Net Income|Expected Profit Maximus, Inc.|MMS - Price to Earnings Ratio|Future Price to Earnings Maximus Corp|MMS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Maximus Health|MMS - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Maximus|MMS - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth maximus.com|MMS - Earnings per share growth this year|Net earnings per share growth forecast for next year Maximus, Inc.
- sales volume and revenue indicators:
MMS - Company Gross Revenue|Company Future Sales Volume Maximus|MMS - Market Cap to Sales Volume|Price-to-Projected Revenue Ratio Maximus Health
Fundamental company valuation:Maximus MMS
Product sample of Maximus, Inc.

Maximus, Inc. serves as a key operator of large-scale US government programs, providing the business with exceptional stability and systemic trust from authorities. By analyzing the forward price-to-sales ratio, an investor compares market capitalization with projected revenues, which allows for the identification of an overbought asset or the confirmation of current price stability through the lens of the company's future efficiency.

Competitors of Maximus, Inc. (MMS)

Price-to-Projected Revenue Ratio UnitedHealth UNH|CI - Forward Price-to-Revenue Multiple|AFL: Forward Price-to-Revenue Multiple|HUM - Forward P/S Multiple|Centene Corporation (CNC) - Price-to-Projected Revenue Ratio|MOH - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple OSCR|CLOV: Forward Price to Sales|Forward P/S Multiple CTEV|Market Cap to Expected Sales Ratio Yuanbao Corp|Price-to-Projected Revenue Ratio Health In Tech HIT|EHTH: Market Cap to Projected Revenue|GoHealth - Forward P/S Multiple|NeueHealth, Inc. (NEUE) - Forward Price-to-Revenue Multiple|RELI (Reliance Global) - Forward Price-to-Revenue Multiple|LIFW - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio MultiPlan Corporation